A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma

A (Sonia) Buist, William M. Vollmer, Sandra R. Wilson, E. Ann Frazier, Arthur D. Hayward

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Objective: To determine whether peak flow monitoring has value above and beyond symptom monitoring when used as part of an asthma management plan. Methods: From a large managed-care organization, 296 adults, aged 50-92 yr, were recruited and randomly assigned in equal numbers to either use of symptoms or peak flow rate (twice daily or "as needed") for asthma monitoring, and monitored every 6 mo for 2 yr. Interventions were delivered in four 90-min small-group classes and included a personalized action plan and coaching in proper use of asthma inhalers. Results: We found no significant differences between peak flow rate and symptom monitoring, or between twice-daily and as-needed peak flow monitoring in the primary or secondary study outcomes: health care utilization (acute, nonacute, or total asthma visits), Asthma Quality-of-Life Questionnaire (AQLQ) scores, and lung function. AQLQ scores and prebronchodilator FEV1 increased significantly for both groups between baseline and 6 mo (AQLQ: mean, 0.4 units; 95% confidence interval, 0.3, 0.5; p <0.0001; FEV1% predicted: mean, 4%). Inhaler technique improved substantially in both groups. Conclusions: Peak flow monitoring has no advantage over symptom monitoring as an asthma management strategy for older adults with moderate-severe asthma when used in a comprehensive asthmamanagement program. Improved outcomes in both groups suggest that understanding proper medication use, regular monitoring of asthma status, and understanding how to respond to changes are of primary importance.

Original languageEnglish (US)
Pages (from-to)1077-1087
Number of pages11
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume174
Issue number10
DOIs
StatePublished - Nov 15 2006

Fingerprint

Asthma
Randomized Controlled Trials
Nebulizers and Vaporizers
Quality of Life
Patient Acceptance of Health Care
Managed Care Programs
Outcome Assessment (Health Care)
Organizations
Confidence Intervals
Lung
Surveys and Questionnaires

Keywords

  • Health care utilization
  • Lung function
  • Quality of life
  • Self-management

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. / Buist, A (Sonia); Vollmer, William M.; Wilson, Sandra R.; Frazier, E. Ann; Hayward, Arthur D.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 174, No. 10, 15.11.2006, p. 1077-1087.

Research output: Contribution to journalArticle

Buist, A (Sonia) ; Vollmer, William M. ; Wilson, Sandra R. ; Frazier, E. Ann ; Hayward, Arthur D. / A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. In: American Journal of Respiratory and Critical Care Medicine. 2006 ; Vol. 174, No. 10. pp. 1077-1087.
@article{760f199fb708470db57141fe53d9a3c1,
title = "A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma",
abstract = "Objective: To determine whether peak flow monitoring has value above and beyond symptom monitoring when used as part of an asthma management plan. Methods: From a large managed-care organization, 296 adults, aged 50-92 yr, were recruited and randomly assigned in equal numbers to either use of symptoms or peak flow rate (twice daily or {"}as needed{"}) for asthma monitoring, and monitored every 6 mo for 2 yr. Interventions were delivered in four 90-min small-group classes and included a personalized action plan and coaching in proper use of asthma inhalers. Results: We found no significant differences between peak flow rate and symptom monitoring, or between twice-daily and as-needed peak flow monitoring in the primary or secondary study outcomes: health care utilization (acute, nonacute, or total asthma visits), Asthma Quality-of-Life Questionnaire (AQLQ) scores, and lung function. AQLQ scores and prebronchodilator FEV1 increased significantly for both groups between baseline and 6 mo (AQLQ: mean, 0.4 units; 95{\%} confidence interval, 0.3, 0.5; p <0.0001; FEV1{\%} predicted: mean, 4{\%}). Inhaler technique improved substantially in both groups. Conclusions: Peak flow monitoring has no advantage over symptom monitoring as an asthma management strategy for older adults with moderate-severe asthma when used in a comprehensive asthmamanagement program. Improved outcomes in both groups suggest that understanding proper medication use, regular monitoring of asthma status, and understanding how to respond to changes are of primary importance.",
keywords = "Health care utilization, Lung function, Quality of life, Self-management",
author = "Buist, {A (Sonia)} and Vollmer, {William M.} and Wilson, {Sandra R.} and Frazier, {E. Ann} and Hayward, {Arthur D.}",
year = "2006",
month = "11",
day = "15",
doi = "10.1164/rccm.200510-1606OC",
language = "English (US)",
volume = "174",
pages = "1077--1087",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "10",

}

TY - JOUR

T1 - A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma

AU - Buist, A (Sonia)

AU - Vollmer, William M.

AU - Wilson, Sandra R.

AU - Frazier, E. Ann

AU - Hayward, Arthur D.

PY - 2006/11/15

Y1 - 2006/11/15

N2 - Objective: To determine whether peak flow monitoring has value above and beyond symptom monitoring when used as part of an asthma management plan. Methods: From a large managed-care organization, 296 adults, aged 50-92 yr, were recruited and randomly assigned in equal numbers to either use of symptoms or peak flow rate (twice daily or "as needed") for asthma monitoring, and monitored every 6 mo for 2 yr. Interventions were delivered in four 90-min small-group classes and included a personalized action plan and coaching in proper use of asthma inhalers. Results: We found no significant differences between peak flow rate and symptom monitoring, or between twice-daily and as-needed peak flow monitoring in the primary or secondary study outcomes: health care utilization (acute, nonacute, or total asthma visits), Asthma Quality-of-Life Questionnaire (AQLQ) scores, and lung function. AQLQ scores and prebronchodilator FEV1 increased significantly for both groups between baseline and 6 mo (AQLQ: mean, 0.4 units; 95% confidence interval, 0.3, 0.5; p <0.0001; FEV1% predicted: mean, 4%). Inhaler technique improved substantially in both groups. Conclusions: Peak flow monitoring has no advantage over symptom monitoring as an asthma management strategy for older adults with moderate-severe asthma when used in a comprehensive asthmamanagement program. Improved outcomes in both groups suggest that understanding proper medication use, regular monitoring of asthma status, and understanding how to respond to changes are of primary importance.

AB - Objective: To determine whether peak flow monitoring has value above and beyond symptom monitoring when used as part of an asthma management plan. Methods: From a large managed-care organization, 296 adults, aged 50-92 yr, were recruited and randomly assigned in equal numbers to either use of symptoms or peak flow rate (twice daily or "as needed") for asthma monitoring, and monitored every 6 mo for 2 yr. Interventions were delivered in four 90-min small-group classes and included a personalized action plan and coaching in proper use of asthma inhalers. Results: We found no significant differences between peak flow rate and symptom monitoring, or between twice-daily and as-needed peak flow monitoring in the primary or secondary study outcomes: health care utilization (acute, nonacute, or total asthma visits), Asthma Quality-of-Life Questionnaire (AQLQ) scores, and lung function. AQLQ scores and prebronchodilator FEV1 increased significantly for both groups between baseline and 6 mo (AQLQ: mean, 0.4 units; 95% confidence interval, 0.3, 0.5; p <0.0001; FEV1% predicted: mean, 4%). Inhaler technique improved substantially in both groups. Conclusions: Peak flow monitoring has no advantage over symptom monitoring as an asthma management strategy for older adults with moderate-severe asthma when used in a comprehensive asthmamanagement program. Improved outcomes in both groups suggest that understanding proper medication use, regular monitoring of asthma status, and understanding how to respond to changes are of primary importance.

KW - Health care utilization

KW - Lung function

KW - Quality of life

KW - Self-management

UR - http://www.scopus.com/inward/record.url?scp=33751106930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751106930&partnerID=8YFLogxK

U2 - 10.1164/rccm.200510-1606OC

DO - 10.1164/rccm.200510-1606OC

M3 - Article

C2 - 16931634

AN - SCOPUS:33751106930

VL - 174

SP - 1077

EP - 1087

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 10

ER -